Clinical Trials Browser

Neoplasms × N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide × Clear all

NCT06150157 2026-03-16

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Phase 1 Recruiting

Neoplasms

NCT03441113 2024-05-16

Extended Access of Momelotinib in Adults With Myelofibrosis

Phase 2 Active not recruiting

Neoplasms, Primary Myelofibrosis